How Privacy Considerations Drive Patient Decisions and Impact Patient Care Outcomes

How Privacy Considerations Drive Patient Decisions and Impact Patient Care Outcomes
In September 2011, FairWarning® commissioned New London Consulting to develop a survey of United Kingdom patients of care providers to determine how patient privacy considerations impact the actual delivery of healthcare and to what degree patients believed healthcare executives and managers should be held accountable for healthcare privacy protections and breaches. The survey was designed to garner a baseline understanding of patient beliefs relative to a care providers' legal, ethical and moral responsibility to protect patient privacy. More importantly, the survey sought to measure how privacy considerations affect patient behaviours and decisions and influence patient care outcomes.

The survey was conducted using an online platform. Survey invitations were sent to more than 9,349 patients across the United Kingdom. Invitations to participate were sent to residents of England, Scotland, Wales, and Northern Ireland. The survey resulted in responses from participants of varying race, educational level, economic class, age and gender. The survey invitation resulted in participation of 1001 respondents.

Download: How Privacy Considerations Drive Patient Decisions and Impact Patient Care Outcomes (.pdf, 853 KB).

Download from eHealthNews.eu Portal's mirror: How Privacy Considerations Drive Patient Decisions and Impact Patient Care Outcomes (.pdf, 853 KB).

Related news article:

Most Popular Now

Researchers Capture First Images of Oxyg…

Oxygen in cancer tumors is known to be a major factor that helps radiation therapy be successful. Hypoxia, or starvation of oxygen, in solid tumors is also thought to be...

VTT Makes New Investments in Digital Hea…

VTT is launching new research activities in the area of digital health as part of the growing wellbeing and health technology ecosystem in Kuopio. The new initiative aims to create...

A New Method of Artificial Intelligence …

Despite the immense progress in the field of AI in recent years, we are still very far from human intelligence. Indeed, if current AI techniques allow to train computer agents...

FDA Informs Health Care Providers, Facil…

Today, the U.S. Food and Drug Administration is issuing a safety communication informing health care providers, facilities and patients about cybersecurity vulnerabilities identified for certain GE Healthcare Clinical Information Central...

eHealthWeek 2020 Croatia - Trusted Infor…

15 - 17 April 2020, Rovinj, Croatia. In its capacity of hosting the upcoming Presidency of the Council of the European Union, the Croatian Ministry of Health is in preparations to...

Siemens Healthineers Presents Solutions …

CT scanners with intelligent user guidance, AI-based software assistants for MRI and a lab system that revolutionizes workflows: Siemens Healthineers is showcasing its products and solutions according to the motto...

NHS IT Chiefs Set the Stage for a Year o…

3 - 4 March 2019, London, United Kingdom. NHS technology leaders are to kick off the second-ever Digital Health Rewired Conference and Exhibition on 3 - 4 March at the Olympia...

PatchAi Startup has Arrived in the Marke…

PatchAi - a startup that offers, thanks to Artificial Intelligence and Machine Learning, an empathic virtual assistant to patients participating in clinical trials - announced that it has closed two...

Digital Health App Medicus AI Earns CE C…

Medicus AI, the Vienna-based health tech company, has received a ​Class I Medical Device CE Mark for its mobile application. The CE certification mark confirms that Medicus AI conforms to...

FDA Authorizes Marketing of First Cardia…

Today, the U.S. Food and Drug Administration authorized marketing of software to assist medical professionals in the acquisition of cardiac ultrasound, or echocardiography, images. The software, called Caption Guidance, is...

Human Body-on-Chip Platform Enables In V…

Drug development is an extremely arduous and costly process, and failure rates in clinical trials that test new drugs for their safety and efficacy in humans remain very high. According...

AI in Drug Discovery Conference 2020

16 - 17 March 2020, London, UK. SMi group presents the launch of the inaugural AI in Drug Discovery conference taking place in London. AI-empowered machine learning technologies hold the potential...